Document Detail


Vigabatrin reduces epileptiform activity in brain slices from pharmacoresistant epilepsy patients.
MedLine Citation:
PMID:  10924922     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human neocortical temporal lobe tissue resected for treatment of pharmacoresistant epilepsy was investigated. In slices prepared from this tissue, epileptiform field potentials (EFP) were induced by omission of magnesium from the artificial cerebrospinal fluid (ACSF). The effects of the gamma-aminobutyric acid transaminase inhibitor vigabatrin on EFP were tested. Vigabatrin exerted a dose-dependent reduction of the repetition rate of EFP: after 3 h of administration of vigabatrin in concentrations of 100 and 200 micromol/l, the repetition rate of EFP was reduced to 35% and 18% of the initial values, respectively. This effect was not reversible. In control experiments with neocortical slices from rats, vigabatrin reduced EFP in a comparable range. The results demonstrate a strong antiepileptic effect of vigabatrin on EFP in tissues from pharmacoresistant epilepsy patients.
Authors:
U Musshoff; R Köhling; A Lücke; E Speckmann; I Tuxhorn; P Wolf; H W Pauuek; F Oppel
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pharmacology     Volume:  401     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-10-12     Completed Date:  2000-10-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  167-72     Citation Subset:  IM    
Affiliation:
Institut für Physiologie, Universität Münster, Robert-Koch-Str. 27a 48149, Münster, Germany. mushoff@uni-muenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Animals
Anticonvulsants / pharmacology*
Brain / drug effects*,  physiopathology
Dose-Response Relationship, Drug
Drug Resistance
Electrophysiology
Epilepsy / physiopathology,  prevention & control*
Epilepsy, Temporal Lobe / physiopathology,  prevention & control
Female
Humans
Male
Middle Aged
Neostriatum / drug effects,  physiopathology
Rats
Vigabatrin / pharmacology*
Chemical
Reg. No./Substance:
0/Anticonvulsants; 60643-86-9/Vigabatrin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blockade of lipopolysaccharide-induced fever by a mu-opioid receptor-selective antagonist in rats.
Next Document:  Mediation of ionotropic glutamate receptors in domoic acid-induced striatal dopamine release in rats...